Commonwealth Bank of Australia
Commonwealth Bank of Australia (CMWAY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Commonwealth Bank of Australia (CMWAY), covering cash flow, earnings, and balance sheets.
Commonwealth Bank of Australia (CMWAY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Commonwealth Bank of Australia CMWAY financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $34.00B | $31.73B | $27.07B | $21.82B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $34.00B | $31.73B | $27.07B | $21.82B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.10B | $5.40B | $5.41B | $5.28B |
| Operating Expenses | $2.05B | $1.89B | $2.002B | $1.87B |
| Total Costs & Expenses | $27.19B | $24.53B | $20.30B | $14.13B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $5.79B | $4.87B | $4.15B | $2.81B |
| Depreciation & Amortization | $742.00M | $698.00M | $535.00M | $575.00M |
| EBITDA | $7.51B | $7.84B | -$224.00M | -$398.00M |
| EBITDA Ratio | $0.22 | -$0.01 | -$0.008 | -$0.02 |
| Operating Income | $6.81B | $7.47B | $7.12B | $7.87B |
| Operating Income Ratio | $0.20 | $0.24 | $0.26 | $0.36 |
| Other Income/Expenses (Net) | -$36.00M | -$359.00M | -$352.00M | -$413.00M |
| Income Before Tax | $6.77B | $7.11B | $6.77B | $7.46B |
| Income Before Tax Ratio | $0.20 | $0.22 | $0.25 | $0.34 |
| Income Tax Expense | $2.07B | $2.23B | $1.93B | $2.23B |
| Net Income | $4.65B | $4.76B | $4.98B | $5.14B |
| Net Income Ratio | $0.14 | $0.15 | $0.18 | $0.24 |
| EPS | $2.94 | $2.84 | $2.96 | $3.04 |
| Diluted EPS | $2.78 | $2.82 | $2.80 | $2.84 |
| Weighted Avg Shares Outstanding | $1.67B | $1.67B | $1.69B | $1.70B |
| Weighted Avg Shares Outstanding (Diluted) | $1.77B | $1.79B | $1.78B | $1.81B |
Over the past four quarters, Commonwealth Bank of Australia demonstrated steady revenue growth, increasing from $21.82B in Q2 2023 to $34.00B in Q4 2024. Operating income reached $6.81B in Q4 2024, maintaining a consistent 20% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $7.51B, reflecting operational efficiency. Net income dropped to $4.65B, with EPS at $2.94. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan